Journals / MN Kardiyoloji / 2019 / Cilt: 26 - Sayı: 4

The Relationship Between Serum Triglyceride Levels and Acute Stent Thrombosis

Akut Stent Trombozu Gelişimi ile Serum Trigliserid Seviyeleri Arasındaki İlişkinin Değerlendirilmesi

Pages
213–219
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Addition of this laboratory measurement to clinical and angiographic risk factors for acute stent thrombosis, may contribute to determination of high-risk patients for stent thrombosis after percutaneous coronary intervention.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Acute stent thrombosis is a fatal complication of percutaneous coronary intervention that may be associated with myocardial infarction and sudden death which occurs within the 24 hour of procedure.
📊
Key Findings & Data:Material and Method: Between January 2013 and December 2017, a total of 7.512 patients who underwent coronary angiography due to stable coronary artery disease were evaluated retrospectively.
💡
Conclusion & Impact:Addition of this laboratory measurement to clinical and angiographic risk factors for acute stent thrombosis, may contribute to determination of high-risk patients for stent thrombosis after percutaneous coronary intervention.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Acute stent thrombosis is a fatal complication of percutaneous coronary intervention that may be associated with myocardial infarction and sudden death which occurs within the 24 hour of procedure. Dyslipidemia is a well-known risk factor for cardiovascular disease. The residual risk remains high even though the target low density lipoprotein cholesterol values have been achieved with effective statin therapy. In this study, we aimed to investigate relationship between stent thrombosis and triglyceride value on admission in patients with stabile coronary artery disease who underwent percutaneous coronary intervention. Material and Method: Between January 2013 and December 2017, a total of 7.512 patients who underwent coronary angiography due to stable coronary artery disease were evaluated retrospectively. Among those patients, 122 patients developed in-hospital acute stent thrombosis were identified. 24 patients who were thought to have developed stent thrombosis due to technical reasons (edge dissection, undersize stent selection, inadequate stent ekspantion vs) were excluded from the study. A total of 98 patients with acute stent thrombosis and 502 patients as control group were included in the study. The predictive value of triglyceride levels were investigated in predicting acute stent thrombosis. Results: Stent length, total cholesterol, triglyceride, low density lypoprotein cholesterol, white blood cell count, fibrinogen, and uric acid levels were significantly higher in the group with stent thrombosis compared to the control group. Stent length, fibrinogen, uric acid, white blood cell and triglyceride levels were independent predictors of acute stent thrombosis in multivariate regression analysis. Conclusion: Increased triglyceride levels were found as the independent predictor of acute stent thrombosis in patients undergoing elective percutaneous coronary intervention. Addition of this laboratory measurement to clinical and angiographic risk factors for acute stent thrombosis, may contribute to determination of high-risk patients for stent thrombosis after percutaneous coronary intervention.

Özet

Amaç: Akut stent trombozu, işlemin ilk 24 saati içinde gelişen miyokard enfarktüsü ve ani ölümle ilişkili olabilen perkütan koroner girişimin ölümcül bir komplikasyonudur. Dislipidemi kardiyovasküler hastalıklar için iyi bilinen bir risk faktörüdür. Etkin statin tedavisiyle hedef düşük yoğunluklu lipoprotein kolesterol değerlerine ulaşılmasına rağmen rezidü risk yüksek kalmaya devam etmektedir. Bu çalışmada perkütan koroner girişim yapılan stabil koroner arter hastalarında stent trombozu ile başvuru esnasındaki trigliserid değeri arasındaki ilişkiyi araştırmayı amaçladık. Gereç ve Yöntem: Stabil koroner arter hastalığı sebebiyle Ocak 2013 ile Aralık 2017 aralığında koroner anjiografi yapılan toplamda 7.512 hasta retrospektif olarak değerlendirildi. Hastane içi akut stent trombozu gelişen toplamda 122 hasta tanımlandı. Teknik sebeplere bağlı stent trombozu geliştiği düşünülen (sınır diseksiyonu, undersize stent seçimi, yetersiz stent ekspansiyonu vs.) 24 hasta çalışma dışında bırakıldı. Akut stent trombozu gelişen 98 hasta ve kontrol grubu olarak 502 hasta çalışmaya dahil edildi. Akut stent trombozunu öngörmede trigliserid düzeylerinin prediktif değeri araştırıldı. Bulgular: Stent trombozu gelişen grupta kontrol grubuna kıyasla stent uzunluğu, total kolesterol, trigliserid seviyesi,düşük yoğunluklu lipoprotein kolesterol seviyesi, beyaz küre sayısı, fibrinojen ve ürik asit seviyesi kontrol grubuna göre anlamlı olarak daha fazla saptandı. Yapılan çok değişkenli regresyon analizinde stent uzunluğu, fibrinojen, ürik asit, beyaz küre sayısı ve trigliserid seviyeleri akut stent trombozunu öngörmede bağımsız değişkenler olarak bulundu. Sonuç: Artmış trigliserid seviyeleri, elektif perkütan koroner girişim sonrası akut stent trombozunu öngörmede önemli bir değişken olarak bulundu. Stent trombozuyla ilişkili olduğu bilinen klinik ve anjiyografik parametrelere bu laboratuvar bulgusunun da dahil edilmesi, stent trombozu açısından yüksek riskli hastaların belirlenmesine katkı sağlayabilir.

🔖

Cite This Article

GÜL, M., AÇAR, B., ŞAHAN, E., İNCİ, S. (2019). The Relationship Between Serum Triglyceride Levels and Acute Stent Thrombosis. MN Kardiyoloji, Cilt: 26 - Sayı: 4, 213–219. https://ajindex.com/articles/297271

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Baigent C, Keech A, Kearney PM, et al. Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterol-loweringctreatment: prospective metaanalysis of data from 90,056 participants inc14 randomised trials of statins. Lancet. 2005;366(9493):1267-78
  2. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the NationalCholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227-39
  3. Fulcher J, O’Connell R, Voysey M. et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385(9976):1397-405 4. Robinson JG. Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin. Vasc Health Risk Manag. 2009;5(1):31-43 5. Kern MJ. Thinking about stent thrombosis: how does angiographic flow relate to outcome? Catheter Cardiovasc Interv. 2015;85:23-4
  4. Tyczynski P, Karcz MA, Kalinczuk L, et al. Early stent thrombosis. Aetiology, treatment, and prognosis. Postepy Kardiol Interwencyjnej. 2014;10:221-5
  5. Dangas GD, Caixeta A, Mehran R, et al. Stents in Acute Myocardial Infarction Trial I. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation. 2011 26;123(16):1745-56
  6. Klempfner R, Erez A, Sagit BZ, et al. Elevated Triglyceride Level Is Independently Associated With Increased AllCause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry. Circ Cardiovasc Qual Outcomes. 2016;9(2):100-8
  7. Yüksel M, Bilik MZ, Demir M, et al. The Predictive Value of RDW on Admission for Stent Thrombosis in Patients Underwent Primary Percutaneous Coronary Intervention. Eur J Health Sci. 2015;1(1):27-35
  8. Otsuka M, Hayashi Y, Ueda H, Imazu M, Kohno N. Predicti - ve value of preprocedural fibrinogen concerning coronary stenting. Atherosclerosis. 2002;164:371-8
  9. Kavitha S, Sridhar MG, Satheesh S. Periprocedural plasma fibrinogen levels and coronary stent outcome. Indian Heart J. 2015;67(5):440-3
  10. Battelli MG, Polito L, Bolognesi A. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress. Atherosclerosis. 2014;237(2):562-7
  11. Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A. The relationships among hyperuricemia, endothelial dysf